Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Piramal Group

Tracked across 9 events · 96 articles · First seen Dec 19, 2025 · Last active Aug 18, 2026

Sentiment
31
Attention
4
Events
9
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 20
Business
Impact: Piramal Group announced its Q4 and full-year FY26 results, reporting a decline in revenue and EBITDA but expressing optimism for FY27 growth across its businesses. The company also recognized an impairment loss of ₹176 crore.
Apr 28, 2026 · 14 articles
2 10
Business
Impact: Piramal Group is the subject of the report, showcasing its FY2026 performance, strategic investments, and sustainability progress.
Jul 07, 2026 · 14 articles
2 40
Business
Impact: Piramal Group is the reporting company; its Q1 results show strong revenue growth and margin expansion, positively impacting its financial outlook.
Jul 29, 2026 · 10 articles
2 40
Business
On August 18, 2026, Piramal Group (PPL) completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based CDMO specializing in vaccines and biologics, for a cash consideration of ₹76 crore (approximately $7.95…
Impact: Acquirer; completed acquisition of controlling stake in Yapan Bio, expanding its biologics CDMO capabilities and integrating Yapan Bio as a subsidiary.
Jul 20, 2026 · 11 articles
2 15
Business
Piramal Enterprises — Piramal Pharma Solutions (PPS), a CDMO and part of Piramal Group, launched a new spray drying suite at its dedicated peptide development and manufacturing facility in Turbhe, India. The suite is a…
Impact: Parent company of PPS; benefits from enhanced CDMO capabilities and potential revenue growth.
Aug 04, 2026 · 12 articles
4 60
Business
Impact: Piramal Group's subsidiary, Piramal Enterprises — Piramal Pharma Solutions, entered a strategic collaboration, which is expected to positively impact the parent company's market position and offerings.
Apr 16, 2026 · 11 articles
2 40
Business
Impact: Piramal Group, as the parent company of Piramal Enterprises — Piramal Pharma Solutions, benefits from the expansion of its subsidiary's manufacturing capabilities, which supports its overall growth strategy in the pharmaceutical sector.
May 13, 2026 · 11 articles
2 50
Business
Impact: Piramal Group is a customer of Smallest.ai, using its voice AI platform. This relationship could benefit Piramal Group's customer service operations.
Jul 30, 2026 · 7 articles
4 0
Business
Impact: Piramal Group previously invested in the Shriram Group and sold its pharmaceutical business.
Dec 19, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Piramal Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.